Recent Circulars
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSE announces listing of 40,86,162 equity shares of Regency Fincorp Limited issued on preferential basis pursuant to conversion of warrants, … | |||||||||||||||
BSE announces listing of 40,86,162 equity shares of Regency Fincorp Limited issued on preferential basis pursuant to conversion of warrants, effective December 30, 2025.
| |||||||||||||||
40,86,162 equity shares of Regency Fincorp Limited issued on preferential basis pursuant to warrant conversion will be listed and permitted … | |||||||||||||||
40,86,162 equity shares of Regency Fincorp Limited issued on preferential basis pursuant to warrant conversion will be listed and permitted to trade with effect from December 30, 2025.
| |||||||||||||||
BSE announces listing of 25,58,32,190 equity shares of Shah Metacorp Limited issued on preferential basis to promoters and non-promoters, … | |||||||||||||||
BSE announces listing of 25,58,32,190 equity shares of Shah Metacorp Limited issued on preferential basis to promoters and non-promoters, effective December 30, 2025.
| |||||||||||||||
BSE approves listing of 25.58 crore preferential equity shares of Shah Metacorp Limited at Rs. 4.71 per share, with lock-in periods until … | |||||||||||||||
BSE approves listing of 25.58 crore preferential equity shares of Shah Metacorp Limited at Rs. 4.71 per share, with lock-in periods until June 2026 and 2027.
| |||||||||||||||
27,69,000 equity shares of Venmax Drugs And Pharmaceuticals Ltd listed on BSE with effect from December 30, 2025, issued on preferential … | |||||||||||||||
27,69,000 equity shares of Venmax Drugs And Pharmaceuticals Ltd listed on BSE with effect from December 30, 2025, issued on preferential basis pursuant to conversion of warrants.
| |||||||||||||||
27,69,000 equity shares of Venmax Drugs And Pharmaceuticals Ltd listed on BSE with effect from December 30, 2025, issued on preferential … | |||||||||||||||
27,69,000 equity shares of Venmax Drugs And Pharmaceuticals Ltd listed on BSE with effect from December 30, 2025, issued on preferential basis pursuant to conversion of warrants.
| |||||||||||||||
27,69,000 equity shares of Venmax Drugs And Pharmaceuticals Ltd listed on BSE with effect from December 30, 2025, issued on preferential … | |||||||||||||||
27,69,000 equity shares of Venmax Drugs And Pharmaceuticals Ltd listed on BSE with effect from December 30, 2025, issued on preferential basis pursuant to conversion of warrants.
| |||||||||||||||
BSE announces listing of 7,67,407 equity shares of Vivo Bio Tech Ltd. issued on preferential basis pursuant to conversion of warrants, … | |||||||||||||||
BSE announces listing of 7,67,407 equity shares of Vivo Bio Tech Ltd. issued on preferential basis pursuant to conversion of warrants, effective December 30, 2025.
| |||||||||||||||
Listing of 7,67,407 equity shares of Vivo Bio Tech Ltd. issued to non-promoters on preferential basis pursuant to conversion of warrants, … | |||||||||||||||
Listing of 7,67,407 equity shares of Vivo Bio Tech Ltd. issued to non-promoters on preferential basis pursuant to conversion of warrants, effective December 30, 2025.
| |||||||||||||||
BSE notifies listing of commercial paper from 6 companies including 360 ONE Prime Limited, UGRO Capital, DSP Finance, CNH Industrial … | |||||||||||||||
BSE notifies listing of commercial paper from 6 companies including 360 ONE Prime Limited, UGRO Capital, DSP Finance, CNH Industrial Capital, SBICAP Securities, and Himadri Speciality Chemical on debt market segment.
| |||||||||||||||